Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
(Reuters) -Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered via the standard ...
RALEIGH, N.C. (WTVD) -- Katherine Wall and her whole family got COVID-19 in January before vaccines were readily available. She said she has an underlying autoimmune disease and got really sick. "I ...
A new monoclonal antibody treatment has been found to protect chronically ill adults from developing COVID-19. The Phase 3 trial results suggest the novel antibody cocktail, delivered by intramuscular ...
Antibody infusions a 'game-changer' in fight against Covid From left, Melissa Edmister, Jesse Arneson and Leah Scaramuzzo at Logan Health Medical Center on Nov. 9, 2021. (Matt Baldwin/Daily Inter Lake ...
While doctors have stressed the importance of COVID-19 vaccinations, there are also coronavirus treatments helping sick patients stay out of the hospital. Monoclonal antibody therapy is gaining ...
(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients when ...
On November 18, 2021, just a few days before the Omicron variant suddenly revealed itself to the world, the preliminary results of two Phase III clinical trials were announced by AstraZeneca, bringing ...
Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...
Nov 12 (Reuters) - Britain's GSK (GSK.L), opens new tab and partner Vir (VIR.O), opens new tab said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a ...
Nov 12 (Reuters) - Britain's GSK GSK.L and partner Vir VIR.O said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback